Literature DB >> 28238361

Macrophage regulation of B cell proliferation.

Naomi Goldman1, Kornelija Valiuskyte1, Jennifer Londregan1, Adam Swider1, John Somerville1, James E Riggs2.   

Abstract

Unlike organized lymphoid tissue, the tumor microenvironment (TME) often includes a high proportion of immunosuppressive macrophages. We model the TME by culturing peritoneal cavity (PerC) cells that naturally have a high macrophage to lymphocyte ratio. Prior studies revealed that, following TCR ligation, PerC T cell proliferation is suppressed due to IFNγ-triggered inducible nitric oxide synthase expression. In this study we assessed the ability of PerC B cells to respond to surrogate activating signals in the presence of high numbers of macrophages. Surface IgM (BCR) ligation led to cyclooxygenase-mediated, and TLR-4 ligation to IL10-mediated, suppression of PerC B cell proliferation. In contrast, PerC B cells had a robust response to CD40 ligation, which could overcome the suppression generated by the BCR or TLR-4 response. However, the CD40 response was suppressed by concurrent TCR ligation. These results reveal the challenges of promoting B and T cell responses in macrophage-rich conditions that model the TME.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B cell; CD40; Macrophage; Tumor microenvironment

Mesh:

Substances:

Year:  2017        PMID: 28238361      PMCID: PMC5383205          DOI: 10.1016/j.cellimm.2017.02.002

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  64 in total

Review 1.  Emerging cytokine networks in colorectal cancer.

Authors:  Nathan R West; Sarah McCuaig; Fanny Franchini; Fiona Powrie
Journal:  Nat Rev Immunol       Date:  2015-09-11       Impact factor: 53.106

2.  Dendritic cell-dependent inhibition of B cell proliferation requires CD22.

Authors:  Lorna Santos; Kevin E Draves; Mark Boton; Prabhjit K Grewal; Jamey D Marth; Edward A Clark
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

3.  BCR-induced superoxide negatively regulates B-cell proliferation and T-cell-independent type 2 Ab responses.

Authors:  Sabrina M Richards; Edward A Clark
Journal:  Eur J Immunol       Date:  2009-12       Impact factor: 5.532

Review 4.  Characteristics and Significance of the Pre-metastatic Niche.

Authors:  Yang Liu; Xuetao Cao
Journal:  Cancer Cell       Date:  2016-11-14       Impact factor: 31.743

Review 5.  Tumor microenvironment: The culprit for ovarian cancer metastasis?

Authors:  Zhongyue Luo; Qiu Wang; Wayne Bond Lau; Bonnie Lau; Lian Xu; Linjie Zhao; Huiliang Yang; Min Feng; Yu Xuan; Yanfei Yang; Lingzi Lei; Chenlu Wang; Tao Yi; Xia Zhao; Yuquan Wei; Shengtao Zhou
Journal:  Cancer Lett       Date:  2016-04-27       Impact factor: 8.679

6.  Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients.

Authors:  Xin Wei; Yangqiu Jin; Yinpu Tian; Huiyuan Zhang; Jie Wu; Wei Lu; Xiaofen Lu
Journal:  Tumour Biol       Date:  2015-12-05

7.  B16 melanoma cells increase B-1 cell survival, IL-10 production and radioresistance in vitro.

Authors:  Maria Fernanda Lucatelli Laurindo; Felipe Garutti Thies; Elizabeth Cristina Perez; Ronni Rômulo Novaes e Brito; Mario Mariano; Ana Flavia Popi
Journal:  Immunobiology       Date:  2012-08-07       Impact factor: 3.144

8.  Macrophages in human breast disease: a quantitative immunohistochemical study.

Authors:  P M Kelly; R S Davison; E Bliss; J O McGee
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

Review 9.  B cell regulation of the anti-tumor response and role in carcinogenesis.

Authors:  Marc Schwartz; Yu Zhang; Joseph D Rosenblatt
Journal:  J Immunother Cancer       Date:  2016-07-19       Impact factor: 13.751

10.  Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4.

Authors:  Jernej Murn; Olivier Alibert; Ning Wu; Simon Tendil; Xavier Gidrol
Journal:  J Exp Med       Date:  2008-12-15       Impact factor: 14.307

View more
  6 in total

1.  High macrophage PD-L1 expression not responsible for T cell suppression.

Authors:  Naomi Goldman; Yelizavet D Lomakova; Jennifer Londregan; Amanda Bucknum; Kelley DePierri; John Somerville; James E Riggs
Journal:  Cell Immunol       Date:  2017-12-30       Impact factor: 4.868

2.  PHA eludes macrophage suppression to activate CD8+ T cells.

Authors:  Yelizavet D Lomakova; Jennifer Londregan; Jeffrey Maslanka; Naomi Goldman; John Somerville; James E Riggs
Journal:  Immunobiology       Date:  2018-11-03       Impact factor: 3.144

3.  IgD ligation allows peritoneal cavity B cell proliferation.

Authors:  Jennifer Londregan; Jeffrey Maslanka; Naomi Goldman; John Somerville; James E Riggs
Journal:  Immunobiology       Date:  2022-01-20       Impact factor: 3.144

4.  Activation of B-1 Cells Promotes Tumor Cell Killing in the Peritoneal Cavity.

Authors:  Marcela A Haro; Allison M Dyevoich; James P Phipps; Karen M Haas
Journal:  Cancer Res       Date:  2018-09-17       Impact factor: 12.701

5.  Phenotypic and functional alterations of peritoneal macrophages in lupus-prone mice.

Authors:  Gabriela Tejon; Nicolás Valdivieso; Felipe Flores-Santibañez; Verónica Barra-Valdebenito; Víctor Martínez; Mario Rosemblatt; Daniela Sauma; María Rosa Bono
Journal:  Mol Biol Rep       Date:  2022-02-24       Impact factor: 2.742

6.  Therapeutic exosomal vaccine for enhanced cancer immunotherapy by mediating tumor microenvironment.

Authors:  Fangfang Lv; Huifang Liu; Gaoqian Zhao; Erman Zhao; Hongyu Yan; Ruijun Che; Xinjian Yang; Xiaohan Zhou; Jinchao Zhang; Xing-Jie Liang; Zhenhua Li
Journal:  iScience       Date:  2021-12-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.